Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $41,115 | 2,450 | 48.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,236 | 42 | 30.9% |
| Consulting Fee | $14,243 | 7 | 16.8% |
| Travel and Lodging | $2,570 | 18 | 3.0% |
| Education | $649.32 | 14 | 0.8% |
| Gift | $126.09 | 17 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,229 | 152 | $0 (2024) |
| Allergan, Inc. | $9,782 | 80 | $0 (2022) |
| GENZYME CORPORATION | $9,758 | 118 | $0 (2024) |
| Celgene Corporation | $5,011 | 65 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,306 | 271 | $0 (2024) |
| Eisai Inc. | $2,832 | 34 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,317 | 227 | $0 (2024) |
| UCB, Inc. | $2,280 | 173 | $0 (2024) |
| EMD Serono, Inc. | $2,260 | 115 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $2,259 | 57 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,873 | 364 | UCB, Inc. ($662.58) |
| 2023 | $6,546 | 326 | ABBVIE INC. ($1,388) |
| 2022 | $13,033 | 349 | ABBVIE INC. ($7,252) |
| 2021 | $17,735 | 332 | AbbVie Inc. ($9,774) |
| 2020 | $10,222 | 208 | Allergan, Inc. ($7,310) |
| 2019 | $11,376 | 287 | Celgene Corporation ($4,070) |
| 2018 | $6,058 | 299 | LivaNova USA, Inc. ($1,379) |
| 2017 | $13,097 | 383 | GENZYME CORPORATION ($7,856) |
All Payment Transactions
2,548 individual payment records from CMS Open Payments — Page 1 of 102
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: PSYCHIATRY | ||||||
| 12/27/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/23/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Neurology | ||||||
| 12/18/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $42.50 | General |
| 12/18/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/17/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Neurology | ||||||
| 12/15/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Pain Management | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.94 | General |
| Category: Neuroscience | ||||||
| 12/06/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Genetic Disease | ||||||
| 12/03/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: EPILEPSY | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,052 | 27,227 | $616,835 | $255,040 |
| 2022 | 11 | 1,122 | 28,455 | $713,220 | $258,269 |
| 2021 | 11 | 1,211 | 27,281 | $716,800 | $263,926 |
| 2020 | 11 | 1,112 | 25,362 | $662,025 | $230,621 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 47 | 25,700 | $385,500 | $125,319 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 401 | 762 | $121,920 | $72,033 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 263 | $27,615 | $16,954 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 123 | 123 | $28,290 | $15,214 | 53.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 33 | 102 | $30,600 | $13,565 | 44.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 44 | $9,680 | $6,054 | 62.5% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 45 | 45 | $8,550 | $3,195 | 37.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 28 | $3,080 | $1,362 | 44.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 137 | 160 | $1,600 | $1,344 | 84.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 48 | 26,930 | $403,950 | $129,432 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 614 | $142,070 | $58,542 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 281 | 372 | $44,880 | $23,888 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 124 | 124 | $41,000 | $15,782 | 38.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 34 | 100 | $38,000 | $13,539 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 40 | $13,710 | $5,480 | 40.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 13 | 13 | $10,780 | $4,007 | 37.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 48 | 50 | $9,900 | $3,572 | 36.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 51 | 59 | $6,490 | $3,104 | 47.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 13 | $1,040 | $507.43 | 48.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 123 | 140 | $1,400 | $414.72 | 29.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 43 | 25,700 | $385,500 | $122,931 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 362 | 614 | $153,500 | $61,424 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 196 | 233 | $26,795 | $16,768 | 62.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 127 | 127 | $44,450 | $16,661 | 37.5% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 31 | 96 | $38,400 | $13,100 | 34.1% |
About Dr. Lawrence Eilender, MD
Dr. Lawrence Eilender, MD is a Neurology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366445173.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Eilender, MD has received a total of $84,940 in payments from pharmaceutical and medical device companies, with $6,873 received in 2024. These payments were reported across 2,548 transactions from 100 companies. The most common payment nature is "Food and Beverage" ($41,115).
As a Medicare-enrolled provider, Eilender has provided services to 4,497 Medicare beneficiaries, totaling 108,325 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Southfield, MI
- Active Since 05/24/2005
- Last Updated 09/25/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1366445173
Products in Payments
- UBRELVY (Drug) $25,729
- AUBAGIO (Drug) $8,527
- Ozanimod (Drug) $4,070
- KESIMPTA (Drug) $1,570
- TYSABRI (Biological) $1,528
- ONZETRA Xsail (Drug) $1,442
- VNS Therapy (Device) $1,379
- Briviact (Drug) $1,285
- ZEPOSIA (Drug) $1,249
- BOTOX (Biological) $1,167
- QULIPTA (Drug) $1,018
- EMGALITY (Drug) $872.42
- Zembrace (Drug) $825.71
- AUSTEDO (Drug) $779.12
- NUEDEXTA (Drug) $764.32
- INGREZZA (Drug) $763.28
- Aimovig (Biological) $762.71
- NURTEC ODT (Drug) $760.95
- LEMTRADA (Drug) $712.25
- GILENYA (Drug) $679.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Southfield
Dr. Anthony Emmer, D.o, D.O
Neurology — Payments: $214,206
Dr. Tessy Jenkins, M.d, M.D
Neurology — Payments: $34,604
Dr. William Leuchter, M.d, M.D
Neurology — Payments: $7,439
Dr. Rashmi Gupta, Md, MD
Neurology — Payments: $7,116
Ahmad Ahmad, Md, MD
Neurology — Payments: $3,993
Dr. Nancy Cao, Md, Phd, MD, PHD
Neurology — Payments: $3,649